Can a once-daily pill help manage obesity? a new trial puts an experimental drug to the test.
NCT ID NCT07731139
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
This early-stage trial is testing an experimental oral drug called PF-08642534 in adults with obesity. The goal is to see if different doses are safe and how the body processes the drug. Participants will receive either the drug or a placebo once daily for a set period. The study is not designed to measure weight loss but to gather essential safety data.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental oral drug called PF-08642534
- What this could lead to
- If safe and effective, this drug could offer a new oral treatment option for obesity.
- What could go wrong
- This is an early Phase 1 trial focused on safety, not weight loss. The drug may not work or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Orange County Research Center
Lake Forest, California, 92630, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?